Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2026 · View financials
Decision snapshot: IDYA stock price vs WLY: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at WLY's multiple
Needs WLY P/S.
Implied fair value · at IDYA's multiple
Needs IDYA P/S.
Metric by metric
Price unavailable
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: IDYA FY 2025 (ended Dec 31, 2025) · WLY FY 2026 (ended Apr 30, 2026). Fiscal years are not aligned.
Trendline
Ten fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
IDEAYA Biosciences, Inc. · implied price per share
Bear
$0.30
Base
$0.35
Bull
$0.41
JOHN WILEY & SONS, INC. · implied price per share
Bear
$47.39
Base
$55.75
Bull
$64.12
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.07x
0.82x
Net debt / EBITDA
Leverage against operating earnings
5.09x
1.25x
Cash and equivalents
Liquid reserves on the balance sheet
$639.39M
$75.62M
Total debt
Interest-bearing obligations outstanding
$70.35M
$695.90M
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Zentalis Pharmaceuticals, Inc.
IDYA vs ZNTL
Blueprint Medicines Corp
IDYA vs BPMC
Jazz Pharmaceuticals plc
IDYA vs JAZZ
Sarepta Therapeutics, Inc.
IDYA vs SRPT
NEWS CORP
IDYA vs NWSA
NEW YORK TIMES CO
IDYA vs NYT
Barnes & Noble Education, Inc.
IDYA vs BNED
RELX PLC
IDYA vs RELX
SCHOLASTIC CORP
IDYA vs SCHL
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
Live quote
